金活醫藥集團(01110.HK)預期上半年公司擁有人應占溢利增加約20%至25%
格隆匯8月10日丨金活醫藥集團(01110.HK)公佈,集團預期截至2022年6月30日止6個月公司擁有人應占溢利將較去年同期公司擁有人應占溢利人民幣1950萬元增加約20%至25%。
董事會認為公司擁有人應占溢利增加主要是由於新型冠狀病毒(COVID-19)疫情受到控制,使市場在該期間相對前期間有所復甦,致從事品牌進口醫藥及保健產品的中國分銷業務的(i)毛利增加約15%至20%;及(ii)應占一家合營企業溢利增加約145%至150%所致。
董事會亦謹此知會股東及潛在投資者,公司的非全資附屬公司,深圳市東迪欣科技有限公司,一家生產各種醫療設備(包括紅外線探熱器)的醫療設備製造商,並已為其製造的醫療設備取得各項證書及許可證,預期該期間的期內溢利將較前期間減少約5%至10%,主要是由於抗疫情設備之銷售有所回落所致。
基於上文所述,集團預期該期間的集團期內溢利將較前期間的集團期內溢利人民幣3430萬元增加約1%至5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.